February 15, 2024 · Form 4 insider transaction
LEIDEN JEFFREY M sold 4,655 shares of Vertex Pharmaceuticals Incorporated at $419.16 per share, a transaction worth $1.95M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 08/04/2023.